Viewing Study NCT07301268


Ignite Creation Date: 2025-12-24 @ 5:32 PM
Ignite Modification Date: 2025-12-25 @ 3:05 PM
Study NCT ID: NCT07301268
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-12-24
First Post: 2025-12-22
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: GI-102 Alone or in Combination With Pembrolizumab Before Surgery for the Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma
Sponsor: Mayo Clinic
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module